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In the previous issue of the Netherlands Heart Journal,
Rijlaarsdam-Hermsen et al. describe the prognostic
value of the coronary artery calcium (CAC) score in
patients with suspected stable coronary artery disease
[1]. In their study, the researchers correlated clinical
outcome with the CAC scores of 644 stable chest pain
patients who underwent CAC scoring as part of their
diagnostic work-up. Their results show that increasing
CAC scores are associated with an increased risk of
mortality and adverse cardiac events.
A large body of literature has accumulated since
the introduction of CAC scoring in the late 1980s
[2]. Large, multicentre studies have established the
strong prognostic value of CAC scoring in asymp-
tomatic individuals [3, 4]. Absence of CAC, in par-
ticular, correlates with a very favourable outcome.
In a meta-analysis including more than 70,000 study
participants, absence of CAC was correlated with an
event rate of less than 0.5% during a follow-up of
4 years [5]. This ‘power of zero’ was also encountered
in a symptomatic population, albeit with a slightly
higher incidence of cardiovascular events (i.e. 1.8%).
Given the excellent prognosis, the additional value
of further diagnostic testing of symptomatic patients
in the absence of CAC can be debated, especially
those with a low pre-test probability and longstand-
ing complaints that correspond to a steady plaque
build-up with calcification [6]. Once CAC is present,
however, the story becomes more complicated with
regard to how to apply the CAC results in clinical
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management. It is evident that an increase in CAC
concurs with a progressively atherosclerotic state and
a worse clinical outcome [7]. Symptomatic patients
with evidence of coronary artery disease should in
any case receive pharmacotherapeutic treatment and
risk factor modulation, although this has not been
proven specifically for increased CAC scores [8, 9].
The question remains who deserves further investi-
gation and a referral to the catheterisation laboratory.
Those that remain symptomatic despite optimal med-
ical therapy (OMT) are logical candidates. However,
what about those with subsided chest pain after OMT
but elevated CAC scores? Although symptom relief
has been achieved, they may have lesions that war-
rant treatment for prognostic purposes. CAC scoring
does not visualise non-calcified plaques or provide
information on stenosis severity or specific high-risk
plaque features such as positive remodelling and low-
attenuation plaque. The risk of missing an important
finding such as a significant left main coronary artery
stenosis is lurking. With the ever-decreasing radia-
tion gap between CAC scoring and contrast-enhanced
coronary computed tomography angiography (CCTA),
it is becoming more appealing to proceed with CCTA
whilst the patient is on the CT table. The results of
the International Study of Comparative Health Ef-
fectiveness with Medical and Invasive Approaches
(ISCHEMIA) might shed light on this matter [9]. This
large multicentre, randomised study compared an
invasive approach including invasive angiography to
a conservative approach with OMT alone in more
than 5,000 symptomatic patients and moderate to
severe myocardial ischaemia. All patients underwent
CCTA to unmask high-risk patients with a left main
coronary artery stenosis and low-risk patients with
no obstructive coronary artery disease. Hopefully,
the investigators of the ISCHEMIA trial included CAC
scoring as part of the CT acquisition protocol. Having
Coronary artery calcium score: old faithful delivers again 73
Commentary
the combined results of CAC scores, CCTA and clinical
outcome of all patients in this pivotal trial will further
define the role of CAC in a symptomatic population.
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